𝔖 Bobbio Scriptorium

✦ LIBER ✦

Magnetic diagnostics for the first plasma operation in Korea Superconducting Tokamak Advanced Research

✍ Scribed by Lee, S. G.; Bak, J. G.; Ka, E. M.; Kim, J. H.; Hahn, S. H.

Book ID: 120460088
Publisher: American Institute of Physics
Year: 2008
Tongue: English
Weight: 705 KB
Volume: 79
Category: Article
ISSN: 0034-6748
DOI: 10.1063/1.2953587

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fabrication details, calibrations, and i

Fabrication details, calibrations, and installation activities of magnetic diagnostics for Korea Superconducting Tokamak Advanced Research

✍ Lee, S. G.; Bak, J. G. 📂 Article 📅 2006 🏛 American Institute of Physics 🌐 English ⚖ 704 KB

Structural aspect of the problem of desi

Structural aspect of the problem of designing superconducting materials based on Bi-2212 ion-plasma coatings for operation in strong magnetic fields

✍ V. F. Shamrai 📂 Article 📅 2006 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 190 KB

[AIP PLASMA 2005: Int. Conf. on Research

[AIP PLASMA 2005: Int. Conf. on Research and Applications of Plasmas; 3rd German-Polish Conf.on Plasma Diagnostics for Fusion and Applications; 5th French-Polish Seminar on Thermal Plasma in Space and Laboratory - Opole-Turawa (Poland) (6-9 September 2005)] AIP Conference Proceedings - Vacuum Arc Plasma Motion In A Curvilinear Magnetic Field In A Framework Of The Rigid-Rotor Model

✍ Timoshenko, Aleksandr I. 📂 Article 📅 2006 🏛 AIP ⚖ 746 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB